Track market-moving stories before they get noisy

SAN DIEGO, July 24, 2026 (GLOBE NEWSWIRE) --

Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Helen of Troy Limited (NASDAQ: HELE) common stock between April 24, 2024 and October 8, 2025. Helen of Troy markets a variety of consumer goods across several segments.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

What is the class period? April 24, 2024 - October 8, 2025

What are the allegations?

Shareholders allege that Helen of Troy Limited misled investors regarding the ability of Project Pegasus to improve efficiency and effectiveness. According to the complaint, in fiscal year 2023, Helen of Troy initiated Project Pegasus, a “global restructuring program that focused on both efficiency and effectiveness.” As a part of this initiative, the Company invested in a new distribution center in Tennessee to support its targeted growth.

Plaintiff alleges that during the class period, the Company boasted about the “fuel” it was generating from Project Pegasus. Although Helen of Troy admitted to some speed bumps in Project Pegasus, specifically citing “implementation hiccups” with its new Tennessee distribution center, defendants assured investors that “despite the delayed savings related to our Tennessee distribution center, Project Pegasus continues to move forward. We have made good progress on the cost of goods sold work streams, implementing multiple projects that reduce costs and simplify our supplier base.” However, Project Pegasus was not delivering the efficiencies that defendants touted. Rather, unknown to investors, Helen of Troy did not have enough resources or the budget to achieve its stated restructuring or savings goals.

Plaintiff alleges that on October 9, 2025, CEO G. Scott Uzzell reported Helen of Troy’s second quarter results for fiscal year 2026, announcing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share plummeted by 51%, and that these results were caused by significant business disruptions and cost headwinds which the Company expects to persist for the remainder of the year. These disclosures caused Helen of Troy’s stock price to decline by $6.90 per share, or 25%.

What can shareholders do now? You may be eligible to participate in the class action against Helen of Troy Limited. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by August 3, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.

To be notified if a class action against Helen of Troy Limited settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Helen of Troy Limited ("Helen of Troy" or the "Company") (NASDAQ: HELE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Helen of Troy and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until August 3, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Helen of Troy securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]  

On July 9, 2024, Helen of Troy announced its 2025 first quarter results, allegedly reflecting a 49% decrease in earnings per share year-over year and reducing its full year revenue outlook by more than 20%. 

On this news, Helen of Troy's stock price fell nearly 28%.

Then, on July 10, 2025, Helen of Troy announced its 2026 first quarter results, allegedly reflecting a net sales decline of 11% year-over-year and a nearly 60% decline in adjusted earnings per share.  The Company also announced a $414.4 million goodwill impairment.  On this news, Helen of Troy's stock price fell nearly 23%.

Finally, on October 9, 2025, Helen of Troy announced its 2026 second quarter results, allegedly revealing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share fell 51%, and business disruptions and cost headwinds would continue throughout the remainder of the year. 

On this news, Helen of Troy's stock price fell 25%.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980 

SOURCE Pomerantz LLP

On July 22, 2026, Helen Of Troy Ltd (HELE) shares rose 3.3% today to $28.19. The stock has experienced a 52-week range between $13.85 and $30.68, reflecting sig

New York, New York--(Newsfile Corp. - July 21, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/HELE.

Helen of Troy Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Helen of Troy overstated the success and benefits of its Project Pegasus initiative, touting the "fuel" it was generating while downplaying issues such as "implementation hiccups" at its Tennessee distribution center and assuring investors that the project was progressing and delivering cost-saving efficiencies; in reality, Project Pegasus was not delivering the efficiencies Defendants claimed, as the Company lacked sufficient resources and budget to achieve its stated restructuring and cost-savings goals; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for Helen of Troy Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/HELE, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Helen of Troy you have until August 3, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Helen of Troy Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Helen of Troy Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300154

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Helen of Troy Limited (NASDAQ: HELE) during the period April 24, 2024, through October 8, 2025, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment. You may also contact Joseph E. Levi, Esq. at [email protected] or (888) SueWallSt.

Helen of Troy shares suffered multiple corrective declines during the Class Period, including a 27.7% single-day drop on July 9, 2024, a 22.7% decline on July 10, 2025, and a 25% decline on October 9, 2025. The window to apply for lead plaintiff closes on August 3, 2026.

Notice to Institutional Holders

Pension funds, mutual funds, endowments, and other institutional investors that acquired HELE shares during the Class Period face distinct considerations. The securities action contends that Helen of Troy and certain senior officers made materially misleading statements about the progress of Project Pegasus, a global restructuring initiative, while the Company allegedly lacked adequate resources and budget to achieve its stated savings targets of $75 million to $85 million. Institutional holders who purchased shares in reliance on these representations may have incorporated artificially inflated valuations into portfolio models.

ERISA and Fiduciary Considerations

Plan fiduciaries who held HELE in defined benefit or defined contribution portfolios should assess whether the alleged misrepresentations affected investment decisions or asset allocation. The lawsuit asserts that management repeatedly characterized Project Pegasus as "on track" and generating "fuel" for growth, even as the Company's operational performance deteriorated across multiple quarters. Fiduciaries owe a duty of prudence that includes monitoring securities litigation affecting portfolio holdings and evaluating whether participation as lead plaintiff serves the interests of plan beneficiaries.

Fiduciary Obligations and Recovery Options

Institutional investors with the largest documented losses are typically best positioned for lead plaintiff appointment under the PSLRALead plaintiff status provides direct oversight of litigation strategy, settlement negotiations, and counsel selectionParticipation carries no out-of-pocket cost; counsel is compensated on a contingency basis approved by the courtFiduciaries who fail to evaluate lead plaintiff opportunities in cases affecting portfolio holdings may face questions about their monitoring obligationsThe action covers all purchasers of HELE common stock between April 24, 2024, and October 8, 2025Multiple corrective disclosures revealed the alleged gap between management's public optimism and the Company's actual operational trajectory Portfolio Impact Assessment

With approximately 23.1 million shares outstanding and institutional ownership representing a significant portion of the float, the cumulative stock declines during the Class Period represent substantial aggregate portfolio losses across the institutional investor community. The complaint details a pattern in which the Company allegedly maintained positive projections about restructuring progress while internal realities reflected budget constraints, organizational dysfunction, and an inability to achieve targeted labor efficiencies at its Tennessee distribution center.

Contact us to learn more about institutional recovery options or call Joseph E. Levi, Esq. at (888) SueWallSt.

"Institutional investors play a critical role in securities class actions. In the Helen of Troy matter, pension funds and asset managers that held HELE during the Class Period should evaluate whether serving as lead plaintiff aligns with their fiduciary responsibilities to plan participants and beneficiaries." -- Joseph E. Levi, Esq.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

Frequently Asked Questions About the HELE Lawsuit

Q: Who is eligible to join the HELE investor lawsuit? A: Investors who purchased HELE stock or securities between April 24, 2024, and October 8, 2025, and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.

Q: What is the HELE lead plaintiff deadline? A: The deadline to apply for lead plaintiff appointment is August 3, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What documents do I need to make a claim? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I already sold my HELE shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: Can I join a different law firm's lawsuit instead? A: Multiple firms often file competing complaints. The court consolidates and appoints a single lead counsel. Contacting Levi & Korsinsky before August 3, 2026, ensures your losses are considered.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt 
Fax: (212) 363-7171 

Attorney Advertising. Prior results do not guarantee similar outcomes.

LOS ANGELES, July 21, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Helen of Troy Limited, (“Helen of Troy” or the "Company") (NASDAQ: HELE) investors of a class action on behalf of investors that bought securities between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”). Helen of Troy investors have until August 4, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or join the case via https://portnoylaw.com/helen-of-troy-limited. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Helen of Troy operates as a consumer products company.  In 2023, Helen of Troy allegedly initiated Project Pegasus, a global restructuring program that focused on both efficiency and effectiveness.

The Helen of Troy class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that Project Pegasus would not, and was not on track to, realize the savings, efficiency, or effectiveness that Helen of Troy consistently touted.

On July 9, 2024, Helen of Troy announced its 2025 first quarter results, allegedly reflecting a 49% decrease in earnings per share year-over year and reducing its full year revenue outlook by more than 20%.  On this news, the price of Helen of Troy stock fell nearly 28%, according to the complaint.

On July 10, 2025, Helen of Troy announced its 2026 first quarter results, allegedly reflecting a net sales decline of 11% year-over-year and a nearly 60% decline in adjusted earnings per share.  The Helen of Troy class action lawsuit further alleges that Helen of Troy announced a $414.4 million goodwill impairment.  On this news, the price of Helen of Troy stock fell nearly 23%, according to the complaint.

Finally, on October 9, 2025, Helen of Troy announced its 2026 second quarter results, allegedly revealing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share fell 51%, and business disruptions and cost headwinds would continue throughout the remainder of the year.  On this news, the price of Helen of Troy stock fell 25%, according to the complaint.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
[email protected]
310-692-8883
www.portnoylaw.com 

Attorney Advertising

Helen of Troy promised $75-$85 million in Project Pegasus savings and "fuel" for growth; investors instead received a 49% EPS collapse, a $414.4 million goodwill impairment, and cumulative stock losses exceeding $38 per share Helen of Troy promised $75-$85 million in Project Pegasus savings and "fuel" for growth; investors instead received a 49% EPS collapse, a $414.4 million goodwill impairment, and cumulative stock losses exceeding $38 per share

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE).

Shareholders who purchased shares of HELE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=194307&from=3

CLASS PERIOD: April 24, 2024 to October 8, 2025

ALLEGATIONS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that evidence suggests that given the importance of project pegasus to the Company’s business model and finances, the external macroeconomic conditions during the class period, and the Company’s internal budget and resource constraints, at the time these statements were made, defendants knew or should have known that project pegasus would not, and was not on track to, realize the savings, efficiency, or effectiveness that Helen of Troy consistently touted.

DEADLINE: August 3, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=194307&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HELE during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 3, 2026. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Helen of Troy Limited ("Helen of Troy" or the "Company") (NASDAQ: HELE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Helen of Troy and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until August 3, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Helen of Troy securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.

[Click here for information about joining the class action]

On July 9, 2024, Helen of Troy announced its 2025 first quarter results, allegedly reflecting a 49% decrease in earnings per share year-over year and reducing its full year revenue outlook by more than 20%. 

On this news, Helen of Troy's stock price fell nearly 28%.

Then, on July 10, 2025, Helen of Troy announced its 2026 first quarter results, allegedly reflecting a net sales decline of 11% year-over-year and a nearly 60% decline in adjusted earnings per share. The Company also announced a $414.4 million goodwill impairment. On this news, Helen of Troy's stock price fell nearly 23%.

Finally, on October 9, 2025, Helen of Troy announced its 2026 second quarter results, allegedly revealing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share fell 51%, and business disruptions and cost headwinds would continue throughout the remainder of the year. 

On this news, Helen of Troy's stock price fell 25%.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

Alert: HELE Shares Lost Over $38 Per Share Across Three Corrective Disclosures as Project Pegasus Promises Collapsed Under the Weight of Concealed Operational Failures

, /PRNewswire/ -- SueWallSt alerts investors in Helen of Troy Limited (NASDAQ: HELE) of a pending securities class action. Class Period: April 24, 2024 through October 8, 2025. Find out if you could qualify to recover your losses or contact Joseph E. Levi, Esq. at [email protected] | (888) SueWallSt.

Helen of Troy shares suffered four separate corrective declines during the Class Period, losing $24.68 per share (27.7%) on July 9, 2024, $7.04 per share (22.7%) on July 10, 2025, and $6.90 per share (25%) on October 9, 2025. To be considered for lead plaintiff, investors must file by August 3, 2026.

How the Market Repriced HELE After Each Revelation

The first and largest single-day repricing occurred when Helen of Troy reported first quarter fiscal 2025 results that blindsided shareholders. Earnings per share had cratered 49% year-over-year, and the full-year revenue outlook was slashed by more than 20%. The lawsuit contends that management attributed these results to an "unusual number of internal and external challenges" without disclosing that the Company lacked the budget and resources to deliver on its restructuring promises.

The second market shock came when the architect of the Company's turnaround strategy departed abruptly after just 14 months, with no successor in place. The Company itself cited "underperformance in recent years" and sought a replacement with "turnaround/restructuring experience," signaling to the market that the prior strategy had failed.

The Cumulative Damage to Shareholder Value

The July 9, 2024 decline of $24.68 per share (27.7%) followed disclosure of a 49% EPS collapse and a 20%-plus revenue outlook reduction The July 10, 2025 decline of $7.04 per share (22.7%) accompanied an 11% net sales decline, a nearly 60% adjusted EPS drop, and a $414.4 million goodwill impairment The October 9, 2025 decline of $6.90 per share (25%) followed disclosure of an 8.9% quarterly sales decline and a 51% adjusted EPS plunge Each successive disclosure removed a layer of artificial inflation that the complaint alleges was sustained by repeated assurances that Project Pegasus was "on track" and "generating fuel" Why the Market Reacted With Increasing Severity

As set forth in the complaint, each corrective event did not merely reveal bad quarterly numbers. Each stripped away a specific layer of the narrative Defendants had constructed. The first disclosure revealed the gap between projected and actual performance. The CEO departure signaled the strategy's architect could not fix what was broken. The goodwill impairment quantified the permanent destruction of value. The final disclosure confirmed these were not temporary setbacks but structural failures the Company conceded it had "earned [its] way into."

"When companies fail to disclose material information, shareholders may suffer significant losses. The pattern of repeated assurances followed by repeated negative surprises in this case raises important questions about what was known and when." -- Joseph E. Levi, Esq.

Submit your information here or contact Joseph E. Levi, Esq. at (888) SueWallSt.

WHY SUEWALLST: SueWallSt is powered by Levi & Korsinsky LLP. Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. 

Frequently Asked Questions About the HELE Lawsuit

Q: How much did HELE stock drop? A: Shares fell approximately 27.7%, a decline of $24.68 per share, on July 9, 2024, after Helen of Troy disclosed a 49% year-over-year EPS decline and slashed its full-year revenue outlook by over 20%. Additional declines of 22.7% and 25% followed subsequent corrective disclosures. Investors who purchased shares during the class period at artificially inflated prices may be entitled to compensation.

Q: What specific misstatements does the HELE lawsuit allege? A: The complaint alleges Helen of Troy made materially false or misleading statements regarding the progress and effectiveness of Project Pegasus, its global restructuring program, and the operational health of its Tennessee distribution center during the class period. When the true state of affairs was revealed through multiple corrective disclosures, the stock price declined sharply.

Q: What do HELE investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact SueWallSt for a free, no-obligation evaluation at [email protected] or (888) SueWallSt. No immediate action is required to remain eligible as a class member.

Q: What if I already sold my HELE shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: Do I need to go to court or give testimony? A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: Can I join a different law firm's lawsuit instead? A: Multiple firms often file competing complaints. The court consolidates and appoints a single lead counsel. Contacting Levi & Korsinsky before August 3, 2026 ensures your losses are considered.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (888) SueWallSt
Fax: (212) 363-7171 

Attorney Advertising. Prior results do not guarantee similar outcomes.

SOURCE SueWallSt.com

Time-Sensitive: Allegations Focus on Tennessee Distribution Center Failures and Misleading Operational Health Representations That Cost HELE Investors Over $38 Per Share

, /PRNewswire/ -- Levi & Korsinsky, LLP alerts investors in Helen of Troy Limited (NASDAQ: HELE) of a pending securities class action. Class Period: April 24, 2024 through October 8, 2025. Check if you can recover your investment losses or contact Joseph E. Levi, Esq. at [email protected] | (212) 363-7500.

Helen of Troy shares lost $24.68 per share in a single session, a 27.7% collapse, after the Company slashed its full-year revenue outlook by more than 20% and disclosed an "unusual number of internal and external challenges." The stock suffered additional collapses of 22.7% and 25% on July 10, 2025 and October 9, 2025 following additional related disclosures. The Court has set August 3, 2026 as the deadline to apply for lead plaintiff appointment.

The Alleged Tennessee Distribution Center Disruption

A securities class action asserts that Helen of Troy misled shareholders about the operational readiness and efficiency of its new Tennessee distribution center, a cornerstone of the Company's Project Pegasus restructuring program. While management publicly described "implementation hiccups" and assured investors that remediation was "substantially completed," the lawsuit claims these representations masked deeper structural problems. The action contends the facility never achieved its targeted labor efficiencies during the Class Period, undermining the savings and margin expansion that had been promised to the market.

What Management Allegedly Knew About Operational Shortfalls

As alleged in the complaint, the Company's leadership was aware that internal budget and resource constraints prevented the distribution center from reaching the efficiency levels management publicly projected. The lawsuit asserts that statements characterizing the Tennessee facility's challenges as temporary "hiccups" were materially misleading because the problems were systemic. The action claims that:

The Tennessee distribution center's automation system required remediation that took longer and cost more than disclosed Labor efficiency targets at the facility were not achievable within the timeframes communicated to investors The Company lacked sufficient budget and resources to execute the distribution center optimization it repeatedly touted Full-year revenue guidance was reduced by over 20% in part due to these undisclosed operational failures Adjusted earnings per share ultimately declined nearly 60% as internal challenges compounded A $414.4 million goodwill impairment was later recorded, reflecting the depth of operational deterioration Internal and External Challenges: The Phrase That Obscured the Truth

When the Company first acknowledged trouble on July 9, 2024, it attributed disappointing results to an "unusual number of internal and external challenges" without specifying that its flagship distribution investment was failing to deliver. The lawsuit contends this vague characterization allowed the Company to avoid disclosing the severity of its operational problems while continuing to assure investors that Project Pegasus was generating "fuel" for growth.

Speak with an attorney about recovering damages or call (212) 363-7500.

"Investors deserve transparency about material risks that could affect their investments. When a company represents that operational challenges are temporary while internal constraints prevent achievement of stated goals, shareholders are deprived of the information they need to make informed decisions." -- Joseph E. Levi, Esq.

WHY LEVI & KORSINSKY -- Ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

Frequently Asked Questions About the HELE Lawsuit

Q: Who is eligible to join the HELE investor lawsuit? A: Investors who purchased HELE stock or securities between April 24, 2024 and October 8, 2025 and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses, not on whether you still hold the shares.

Q: How much did HELE stock drop? A: Shares fell approximately 27.7%, a decline of $24.68 per share, after the Company disclosed a revenue outlook reduction of over 20% and cited internal and external challenges. Investors who purchased shares during the class period at artificially inflated prices may be entitled to compensation.

Q: What do HELE investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible as a class member.

Q: What is a lead plaintiff and why does it matter? A: A lead plaintiff is the investor appointed by the court to represent the entire class. Lead plaintiffs are typically investors with the largest documented losses. Being appointed does not increase individual recovery but gives direct oversight of how the case is run.

Q: What if I already sold my HELE shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I missed the lead plaintiff deadline? A: The deadline applies only to investors seeking lead plaintiff appointment. Class members who miss it can still participate in any settlement or recovery.

CONTACT:\
Levi & Korsinsky, LLP\
Joseph E. Levi, Esq.\
Ed Korsinsky, Esq.\
33 Whitehall Street, 27th Floor\
New York, NY 10004\
[email protected]\
Tel: (212) 363-7500\
Fax: (212) 363-7171

SOURCE Levi & Korsinsky, LLP

NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Helen of Troy Limited (“Helen of Troy” or the “Company”) (NASDAQ: HELE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Helen of Troy and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until August 3, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Helen of Troy securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]  

On July 9, 2024, Helen of Troy announced its 2025 first quarter results, allegedly reflecting a 49% decrease in earnings per share year-over year and reducing its full year revenue outlook by more than 20%. 

On this news, Helen of Troy’s stock price fell nearly 28%.

Then, on July 10, 2025, Helen of Troy announced its 2026 first quarter results, allegedly reflecting a net sales decline of 11% year-over-year and a nearly 60% decline in adjusted earnings per share.  The Company also announced a $414.4 million goodwill impairment.  On this news, Helen of Troy’s stock price fell nearly 23%.

Finally, on October 9, 2025, Helen of Troy announced its 2026 second quarter results, allegedly revealing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share fell 51%, and business disruptions and cost headwinds would continue throughout the remainder of the year. 

On this news, Helen of Troy’s stock price fell 25%.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT: 
Danielle Peyton 
Pomerantz LLP 
[email protected] 
646-581-9980 ext. 7980 

Key Takeaways Helen of Troy posted 8.2% sales growth in fiscal Q1 2027, with gains in both operating segments.HELE benefited from new products, wider distribution and stronger demand across key leadership brands.Tariffs, freight, currency pressure and cautious spending kept margins and earnings under strain. Helen of Troy Limited (HELE - Free Report) is showing early signs of stabilization as execution improves across its two operating segments.

The investment debate now centers on whether better sales momentum in leadership brands can build a durable recovery while margins remain under pressure from tariffs, costs and cautious consumer spending.

Helen of Troy Rebuilds Core BrandsHelen of Troy is focusing its strategy on leadership brands, including OXO, Hydro Flask, Osprey, Vicks, Braun, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June.

This prioritization is designed to concentrate investment behind brands with clearer consumer relevance, stronger innovation pipelines and better channel potential. It also gives HELE a more disciplined base for restoring momentum after a difficult operating stretch.

The approach resembles the broader consumer-products playbook, where portfolio focus matters. The Clorox Company (CLX - Free Report) also operates through widely recognized household and wellness brands, while Church & Dwight Co., Inc. (CHD - Free Report) competes across fabric care, health and personal care categories.

HELE Gains From Innovation and ReachIn the first quarter of fiscal 2027, Helen of Troy’s consolidated net sales rose 8.2% to $402.1 million, with growth in both segments. Home & Outdoor sales increased 9.5%, while Beauty & Wellness sales rose 7%.

Home & Outdoor benefited from international demand for packs, new product launches and expanded distribution in home and insulated beverageware. Osprey gained from distribution and e-commerce momentum, while OXO and Hydro Flask benefited from wider retail placement and new products.

Beauty & Wellness was helped by nail care, fans and thermometers. The Wellness portfolio also benefited from growth across Braun, Vicks, Honeywell and PUR, supported by expanded distribution and solid point-of-sale trends.

Helen of Troy Expands Beyond the U.S.International growth adds another support to HELE’s recovery story, although the trend is uneven. International sales increased 1.1% in the fiscal first quarter, helped by Osprey distribution improvements and wellness growth.

Management is leaning into a hybrid market model that combines local partners with direct consumer engagement. That approach could help Helen of Troy widen its reach in selected global markets without overextending investment.

The company is still dealing with category-level softness outside the United States. Lower international sales in home and insulated beverageware offset some Home & Outdoor gains, while kitchenware and hair appliances remained weaker areas.

Image Source: Zacks Investment Research

HELE Still Faces Margin PressureSales improvement has not yet produced a clean earnings rebound. Consolidated gross margin declined 110 basis points to 46% in the first quarter of fiscal 2027, mainly due to tariffs, inventory obsolescence and a less favorable customer mix within Home & Outdoor.

Adjusted operating margin slipped 30 basis points to 4%. Adjusted earnings were 17 cents per share, down from 41 cents in the year-ago quarter, despite higher sales and lower interest expense.

The cost backdrop remains challenging. Management expects pressure from commodity inputs, unfavorable Chinese yuan movements, higher inbound and outbound freight and spending to secure supply. A promotional marketplace and cautious retailer purchasing also limit pricing flexibility.

How HELE’s Rank Fits This SetupThe bottom line is that HELE is rebuilding revenue momentum, but the earnings path remains uneven. Better execution, product launches and expanded distribution support the recovery case, while tariff and cost pressures keep profitability visibility limited.

Helen of Troy currently carries a Zacks Rank #3 (Hold). That rank fits a wait-and-see setup, with improving sales trends balanced against margin compression and a cautious consumer backdrop. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

For now, HELE looks like a stabilization story rather than a clean acceleration story. Investors may want clearer evidence that leadership-brand momentum can translate into steadier earnings before treating the recovery as more durable.

LOS ANGELES, July 14, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Helen of Troy Limited, (“Helen of Troy” or the "Company") (NASDAQ: HELE) investors of a class action on behalf of investors that bought securities between May 13, 2025 and February 19, 2026, inclusive (the “Class Period”). Helen of Troy investors have until August 4, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or join the case via https://portnoylaw.com/helen-of-troy-limited. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Helen of Troy operates as a consumer products company.  In 2023, Helen of Troy allegedly initiated Project Pegasus, a global restructuring program that focused on both efficiency and effectiveness.

The Helen of Troy class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that Project Pegasus would not, and was not on track to, realize the savings, efficiency, or effectiveness that Helen of Troy consistently touted.

On July 9, 2024, Helen of Troy announced its 2025 first quarter results, allegedly reflecting a 49% decrease in earnings per share year-over year and reducing its full year revenue outlook by more than 20%.  On this news, the price of Helen of Troy stock fell nearly 28%, according to the complaint.

On July 10, 2025, Helen of Troy announced its 2026 first quarter results, allegedly reflecting a net sales decline of 11% year-over-year and a nearly 60% decline in adjusted earnings per share.  The Helen of Troy class action lawsuit further alleges that Helen of Troy announced a $414.4 million goodwill impairment.  On this news, the price of Helen of Troy stock fell nearly 23%, according to the complaint.

Finally, on October 9, 2025, Helen of Troy announced its 2026 second quarter results, allegedly revealing that quarterly sales were down 8.9% year-over-year, adjusted earnings per share fell 51%, and business disruptions and cost headwinds would continue throughout the remainder of the year.  On this news, the price of Helen of Troy stock fell 25%, according to the complaint.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
[email protected]
310-692-8883
www.portnoylaw.com 

Attorney Advertising

, /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE).

Shareholders who purchased shares of HELE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=193579&from=4

CLASS PERIOD: April 24, 2024 to October 8, 2025

ALLEGATIONS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that evidence suggests that given the importance of project pegasus to the Company's business model and finances, the external macroeconomic conditions during the class period, and the Company's internal budget and resource constraints, at the time these statements were made, defendants knew or should have known that project pegasus would not, and was not on track to, realize the savings, efficiency, or effectiveness that Helen of Troy consistently touted.

DEADLINE: August 3, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=193579&from=4

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HELE during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 3, 2026. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

SOURCE The Gross Law Firm

NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Helen of Troy Limited (NASDAQ: HELE) that a securities class action has been filed on behalf of shareholders who purchased securities between April 24, 2024, and October 8, 2025. Submit your information to recover losses. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

Helen of Troy shares lost over $38 per share across four corrective disclosures, including a single-day decline of $24.68 per share (27.7%). The lead plaintiff deadline is August 3, 2026.

What They Allegedly Knew

The securities action contends that Helen of Troy's senior leadership was aware that Project Pegasus, the company's centerpiece restructuring program, lacked the budget and resources necessary to deliver its promised $75 million to $85 million in savings. The lawsuit maintains that executives personally spearheaded and oversaw the initiative, making it implausible they were unaware of the program's fundamental shortcomings even as they publicly declared it was "generating fuel" and remained "on track."

The Red Flags That Emerged

Plaintiffs assert that multiple warning signs preceded the corrective disclosures:

The company's internal budget and resource constraints were allegedly insufficient to achieve stated restructuring goals, a fact known to leadership before public assurances were madeA new Tennessee distribution center repeatedly failed to achieve targeted labor efficiencies, yet the company continued to characterize the issues as mere "implementation hiccups"Earnings per share declined 49% year-over-year in Q1 FY2025, yet management continued to assure investors the restructuring was "on track" in subsequent quartersThe CEO who spearheaded Project Pegasus departed suddenly after only 14 months, with the company citing "underperformance in recent years" and seeking a replacement with "turnaround/restructuring experience"A $414.4 million goodwill impairment was ultimately recorded in July of 2025, reflecting the severity of revenue deceleration that the action alleges was foreseeable
Inside Knowledge vs. Public Statements

The complaint charges that while leadership privately understood the company had become "too matrixed, too slow, and at times disconnected from each other and the marketplace," public statements painted a starkly different picture. Investors heard that Project Pegasus was "instrumental" in transformation and was delivering "critical fuel for reinvestment." The gap between what was allegedly known internally and what was communicated externally widened over the 18-month Class Period.

Act now to protect your rights or call (212) 363-7500.

"The timeline raises important questions about when certain risks were known internally versus when they were disclosed to the investing public. Shareholders who purchased HELE stock based on repeated assurances about Project Pegasus deserve to understand what leadership knew and when they knew it." -- Joseph E. Levi, Esq.

What Investors Were Not Told

The action alleges investors were not told that macroeconomic conditions and internal constraints had rendered the original Project Pegasus savings plan unachievable. Instead of disclosing these material risks, the complaint contends, leadership continued to tout the program's progress through at least six consecutive earnings calls and investor presentations, maintaining savings estimates that were allegedly no longer realistic.

ABOUT THE FIRM -- Levi & Korsinsky represents investors in securities class actions nationwide, with a track record of recovering hundreds of millions for shareholders harmed by alleged corporate concealment. Ranked among ISS Top 50 for seven consecutive years. Lead plaintiff applications must be submitted by August 3, 2026.

Frequently Asked Questions About the HELE Lawsuit

Q: When did Helen of Troy allegedly mislead investors? A: The class period runs from April 24, 2024, to October 8, 2025. The alleged fraud was revealed through multiple corrective disclosures causing significant cumulative stock declines.

Q: What specific misstatements does the HELE lawsuit allege? A: The complaint alleges Helen of Troy made materially false or misleading statements regarding the progress, resource adequacy, and expected savings of its Project Pegasus restructuring program. When the true state of affairs was revealed, the stock price declined sharply on multiple occasions.

Q: What do HELE investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible as a class member.

Q: What if I already sold my HELE shares -- can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the class period and sold at a loss may still participate.

Q: What does it cost me to participate? A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.

Q: What if I missed the lead plaintiff deadline? A: The deadline applies only to investors seeking lead plaintiff appointment. Class members who miss it can still participate in any settlement or recovery.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

NEW YORK, July 10, 2026 (GLOBE NEWSWIRE) --  The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE).

Shareholders who purchased shares of HELE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.

CONTACT US HERE:

https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=192846&from=3

CLASS PERIOD: April 24, 2024 to October 8, 2025

ALLEGATIONS: According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose that evidence suggests that given the importance of project pegasus to the Company’s business model and finances, the external macroeconomic conditions during the class period, and the Company’s internal budget and resource constraints, at the time these statements were made, defendants knew or should have known that project pegasus would not, and was not on track to, realize the savings, efficiency, or effectiveness that Helen of Troy consistently touted.

DEADLINE: August 3, 2026 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/helen-of-troy-limited-loss-submission-form/?id=192846&from=3

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of HELE during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is August 3, 2026. There is no cost or obligation to you to participate in this case.

WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903

3 Fresh Stock Buybacks: These are the Ones to BuyHelen of Troy NASDAQ: HELE said first-quarter fiscal 2027 results came in ahead of its expectations, with management pointing to stronger sales across both business segments and early progress on a broader effort to restore growth and improve execution.

Chief Executive Officer Scott Uzzell told investors the company is focused on becoming “a better Helen of Troy” before pursuing a bigger growth agenda. He said first-quarter sales exceeded internal expectations in both Home and Outdoor and Beauty and Wellness, while margin and earnings performance reflected intentional investments in brands, innovation and people.

Get Helen of Troy alerts:

Helen of Troy and NanoString Technologies Trade Set-ups “While we’re encouraged by a solid start to the fiscal year, we remain clear-eyed,” Uzzell said. “This is the first year of a multi-year roadmap.”

Sales Rise Across Both Segments Chief Financial Officer Brian Grass said consolidated sales increased 8.2% in the quarter, helped by disciplined execution and improving business fundamentals. He noted that results included approximately $4 million to $5 million of favorable order phasing tied to the earlier timing of Prime Day.

Helen Of Troy Is What We Fear Most About Q2 Earnings Home and Outdoor sales rose 9.5%, with growth across Osprey, OXO and Hydro Flask. Grass said Osprey was the strongest performer, benefiting from improvements in its international distribution network and e-commerce momentum. OXO benefited from lapping prior tariff-related disruption, strong point-of-sale trends and expanded brick-and-mortar distribution, while Hydro Flask growth reflected expanded retail distribution, inventory optimization and e-commerce momentum.

Beauty and Wellness sales increased 7%, with growth in both beauty and wellness. Grass said the wellness portfolio outperformed expectations, driven by Braun, Vicks, Honeywell and PUR. In beauty, Olive & June led growth on expanded distribution, continued innovation and strong consumer engagement, partially offset by softness in some core beauty brands due to ongoing point-of-sale pressure and pricing elasticity.

International sales increased 1.1%, driven by Osprey’s improved distribution network and strength across wellness, partly offset by softer demand in kitchenware and hair appliances in a competitive retail environment.

Brand Innovation and Operating Model Changes Uzzell said North American point-of-sale trends in tracked channels showed year-over-year consolidated growth, concentrated in Braun, Osprey, OXO and Olive & June. He cited several product examples, including Osprey’s Daylite and Transporter expandable travel packs, OXO’s move into pet products, Braun blood pressure monitors in mass channels and Olive & June’s Star Wars-themed collaboration.

“Brands that deliver meaningful innovation and meet real consumer needs can continue to win, even in a more cautious spending environment,” Uzzell said.

Management framed fiscal 2027 as a year to restore momentum under three pillars: consumer-first innovation, commercial and operational excellence, and people and culture. Uzzell said the company is reshaping its operating model to move decision-making closer to consumers and the marketplace.

As part of that change, Helen of Troy has designated five dedicated segment general managers, each responsible for a brand portfolio including strategy, innovation, commercial execution and business results. Uzzell said the roles include both internal leaders and external hires and are not expected to materially increase operating costs. The company also formalized three geographic general manager roles to accelerate brand development outside North America.

Uzzell said the company is also focused on pricing discipline, improving revenue quality, reducing exposure to lower-margin channels and strengthening e-commerce execution, demand planning and alignment across sales, marketing and product teams.

Margins Pressured by Tariffs and Costs Grass said margins and profitability were largely in line with expectations. Consolidated gross profit margin fell 110 basis points to 46%, reflecting the unfavorable impact of tariffs, a less favorable inventory obsolescence impact year over year and a less favorable customer mix in Home and Outdoor.

Adjusted operating margin declined 30 basis points to 4%, due to tariffs and higher investment in the organization and go-to-market structure, partially offset by lower outbound freight and operating leverage. SG&A as a percentage of sales decreased to 31% from 45.1% a year earlier, primarily because of a $55 million pre-tax gain from the sale of a distribution facility disclosed in April, partly offset by higher investment in people.

Inventory ended the quarter at $467 million, down $17 million from the prior year despite approximately $15 million of incremental tariff costs in inventory. Grass said net leverage declined to 3.48 times from 3.87 times at the end of the fourth quarter. Free cash flow was slightly negative, mainly because of tariff payments, annual incentive compensation payments and higher cash taxes, partly offset by higher cash earnings.

Guidance Raised for Sales, Earnings Outlook Maintained Helen of Troy raised its full-year net sales outlook slightly to a range of $1.759 billion to $1.831 billion. The company now expects Home and Outdoor net sales of $859 million to $884 million and Beauty and Wellness net sales of $900 million to $947 million.

The company maintained its adjusted EBITDA outlook of $190 million to $197 million, representing growth of 2.1% to 6.3%, and kept adjusted EPS guidance at $3.25 to $3.75. Free cash flow guidance remained $85 million to $100 million, while planned capital expenditures were increased by $2 million.

Grass said the full-year revenue outlook reflects first-quarter performance, partially offset by the Prime Day-related order pull-forward from the second quarter and revenue risk tied to expected supply disruption, largely from the conflict in the Middle East.

The earnings outlook now includes an estimated $9.2 million pre-tax benefit from phase one tariff refunds. Grass said that benefit is more than offset by expected cost inflation, including higher commodity inputs, unfavorable Chinese yuan fluctuations, increased inbound and outbound freight expense and higher costs to secure goods to avoid supply disruption.

During the question-and-answer session, Grass said the company expects to collect the bulk of the remaining phase one tariff refunds in the second quarter, though later refund phases could extend across several quarters and potentially into fiscal 2028. He said Helen of Troy has paid $71 million in IEEPA tariffs not included in the phase one refund process and expects future refunds could provide upside, but management has not included them in the outlook because timing and collectability remain uncertain.

Management Emphasizes Investment Over Cost Cutting In response to analyst questions, Uzzell said reinvestment priorities include talent, strategic innovation, omnichannel capabilities, supply chain improvements and international market development. Grass added that future tariff refund benefits would likely be used in part to reinvest in the business and in part to offset any cost inflation beyond current assumptions.

On pricing, Uzzell said the company was able to pass through roughly 80% of its intended pricing actions and is monitoring elasticity by brand and category. Grass said overall point-of-sale dollars are growing across the portfolio, although unit trends remain an area of focus in categories where prices increased.

Looking ahead, Grass said the company expects first-half sales growth in the low- to mid-single digits and a low-single-digit decline in the second half at the midpoint of guidance. He said about 20% of annual adjusted EPS is expected in the first half, including roughly 15% in the second quarter.

Uzzell closed the call by saying Helen of Troy remains focused on restoring brand momentum, standing up the new operating model and improving balance sheet productivity.

About Helen of Troy NASDAQ: HELEHelen of Troy Limited is a global consumer products company that designs, sources and markets a diversified portfolio of household, health and beauty brands. Headquartered in El Paso, Texas, the company operates through three principal segments—Health & Home, Housewares and Beauty—offering products under well-known names including OXO, Vicks, Braun, Honeywell Home, PUR and Hot Tools. Helen of Troy distributes its products through a combination of mass, specialty and e-commerce channels to consumers, retailers and distributors worldwide.

The Housewares segment features kitchen tools, gadgets and organizational solutions marketed primarily under the OXO brand, recognized for its ergonomic “Good Grips” design.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Helen of Troy Right Now?Before you consider Helen of Troy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Helen of Troy wasn't on the list.

While Helen of Troy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Key Takeaways Helen of Troy beat FYQ1 estimates as net sales rose 8.2%, though adjusted EPS fell from a year ago.Home & Outdoor sales grew 9.5% on pack demand, launches, distribution gains and order timing.HELE raised fiscal 2027 sales guidance to $1.759B-$1.831B while keeping EPS outlook unchanged. Helen of Troy Limited (HELE - Free Report) reported first-quarter fiscal 2027 results, wherein both top and bottom lines beat the Zacks Consensus Estimate. While net sales increased, earnings decreased from the year-ago period’s actuals. Management raised net sales guidance for fiscal 2027.

HELE’s Quarterly Performance: Key Metrics & InsightsHelen of Troy posted adjusted earnings of 17 cents per share, beating the Zacks Consensus Estimate of 2 cents. However, the bottom line declined 58.5% from 41 cents reported in the year-ago period.

The company reported net sales of $402.1 million, which beat the Zacks Consensus Estimate of $375 million. The top line increased 8.2% from $371.7 million posted in the year-ago period, driven by growth across both business segments. Home & Outdoor benefited from strong international demand for packs, successful new product launches and a favorable comparison to the prior year due to tariff-related order timing. Beauty & Wellness growth was led by strong sales of nail care products, fans and thermometers.

The consolidated gross margin decreased 110 basis points to 46% in the quarter, primarily due to the net unfavorable impact of tariffs, higher inventory obsolescence costs compared with the prior year and a less favorable customer mix within Home & Outdoor. We estimated a 47.5% gross margin.

The consolidated SG&A ratio decreased to 31% from 45.1% posted in the year-ago period, reflecting a $54.9 million pre-tax gain from the sale of a distribution facility, lower outbound freight costs, reduced depreciation and amortization, favorable operating leverage and the absence of $3.5 million in CEO succession costs incurred in the prior-year period.

The adjusted operating income remained flat at $16.1 million, while the adjusted operating margin decreased 30 bps to 4%. The margin compression was primarily caused by tariff-related cost pressures, a less favorable inventory obsolescence impact year over year and an unfavorable customer mix within Home & Outdoor, partially offset by reduced outbound freight costs and favorable operating leverage. We expected an adjusted operating margin of 3% for the quarter.

HELE’s Segmental PerformanceNet sales in the Home & Outdoor segment increased 9.5% to $194.9 million, driven by strong international demand for technical, lifestyle and travel packs, new product launches, expanded distribution in the home and insulated beverageware categories, and a favorable comparison to the prior year due to tariff-related order timing. These gains were partially offset by lower international sales in the home and insulated beverageware categories.

Home & Outdoor adjusted operating income increased 39.2% to $12.3 million, while the segment adjusted operating margin increased 130 bps to 6.3%.

Net sales in the Beauty & Wellness segment gained 7% to $207.2 million, driven by growth in nail care from new and expanded distribution, higher fan and thermometer sales benefiting from an easier comparison against prior-year tariff-related direct import cancellations and disruptions in the China thermometry market, and incremental sales from new Wellness product launches.

Beauty & Wellness adjusted operating income declined 48.2% to $3.8 million, while the segment adjusted operating margin decreased 190 bps to 1.8%.

HELE’s Financial PositionHelen of Troy ended the quarter with cash and cash equivalents of $21.7 million and total short and long-term debt of $716.1 million. Net cash used by operating activities for the fiscal first quarter was $0.6 million. The free cash flow for the same period was negative $6.4 million.

HELE’s OutlookFor fiscal 2027, the company raised its net sales guidance to $1.759-$1.831 billion, from the previous range of $1.751-$1.822 billion. The updated outlook includes Home & Outdoor sales of $859-$884 million (previously $854-$882 million) and Beauty & Wellness sales of $900-$947 million (previously $897-$940 million).

Adjusted earnings are still expected in the range of $3.25 to $3.75 per share, with adjusted EBITDA of $190 million to $197 million and free cash flow of $85 million to $100 million.

Management expects continued inflationary pressures, weak discretionary demand, cautious retailer inventory management and a highly promotional environment. The outlook assumes current tariff rates remain in place, includes $9.2 million in Phase 1 tariff refunds and excludes potential future refunds due to uncertainty. It also factors in higher product and freight costs, unfavorable Chinese yuan movements, and ongoing geopolitical and supply-chain risks that may increase input costs and disrupt supply.

This Zacks Rank #3 (Hold) company has gained 50.5% in the past three months compared with the industry’s growth of 15.4%.

Image Source: Zacks Investment Research

Stocks to ConsiderThe Estee Lauder Companies Inc. (EL - Free Report) manufactures, markets and sells skin care, makeup, fragrance and hair care products worldwide. It currently has a Zacks Rank of 2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Estee Lauder’s current fiscal-year sales and earnings calls for growth of 4.5% and 59.6%, respectively, from the year-ago reported numbers. EL delivered a trailing four-quarter average earnings surprise of 39.1%.

Mama's Creations, Inc. (MAMA - Free Report) manufactures and markets fresh deli-prepared foods in the United States. At present, MAMA holds a Zacks Rank of 2. Mama's Creations delivered a trailing four-quarter earnings surprise of 129.2%, on average.

The consensus estimate for Mama's Creations’ current fiscal-year sales and earnings implies growth of 30% and 73.3%, respectively, from the year-ago figures.

Hormel Foods Corporation (HRL - Free Report) develops, processes and distributes various meat, nuts and other food products to foodservice, convenience store and commercial customers in the United States and internationally. It carries a Zacks Rank of 2 at present. HRL delivered a trailing four-quarter earnings surprise of 3.2%, on average.

The Zacks Consensus Estimate for Hormel Foods’ current fiscal-year sales and earnings indicates growth of 1.5% and 9.5%, respectively, from the prior-year reported levels.

New York, New York--(Newsfile Corp. - July 8, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/HELE.

Helen of Troy Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Helen of Troy overstated the success and benefits of its Project Pegasus initiative, touting the "fuel" it was generating while downplaying issues such as "implementation hiccups" at its Tennessee distribution center and assuring investors that the project was progressing and delivering cost-saving efficiencies; in reality, Project Pegasus was not delivering the efficiencies Defendants claimed, as the Company lacked sufficient resources and budget to achieve its stated restructuring and cost-savings goals; and as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading at all relevant times.What's Next for Helen of Troy Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/HELE, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Helen of Troy you have until August 3, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Helen of Troy Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Helen of Troy Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300150

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Helen of Troy (NASDAQ:HELE) delivered a surprise first-quarter profit and raised its full-year revenue guidance, pointing to early progress in its multi-year restructuring effort.

The consumer products company posted adjusted earnings per share of $0.17 for the quarter, sharply beating the analyst consensus, which had called for a loss of $0.01 per share.

Net sales climbed 8.2% year-over-year to $402.1 million, topping forecasts of roughly $374.5 million. Growth was broad-based, with the Home & Outdoor segment up 9.5% and Beauty & Wellness rising 7%.

Following the results, management raised its fiscal 2027 revenue guidance to a range of $1.76 billion to $1.83 billion. Adjusted earnings guidance was maintained at $3.25 to $3.75 per share, a level the company said reflects stabilization after steep declines in fiscal 2026.

The results build on Project Pegasus, a multi-year restructuring program aimed at modernizing the business and improving operating margins. As part of that effort, Helen of Troy (NASDAQ:HELE) has been diversifying its supply chain to limit exposure to China-related tariffs, targeting China-sourced products at 25% to 30% of consolidated cost of goods sold by the end of fiscal 2026.

Gross margin fell 110 basis points to 46% in the quarter due to tariff pressure and customer mix, though cost savings from Project Pegasus helped offset the impact.

Management said it is focusing marketing and innovation spending on brands including OXO, Hydro Flask and Osprey, aiming to fund reinvestment through revenue growth.

The company's broader portfolio spans the Home & Outdoor and Beauty & Wellness segments and includes Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June.

Shares of Helen of Troy were down 2.2% on Wednesday morning.

Helen of Troy (HELE - Free Report) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +750.00%. A quarter ago, it was expected that this personal and household products company would post earnings of $0.66 per share when it actually produced earnings of $0.83, delivering a surprise of +25.76%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Helen of Troy, which belongs to the Zacks Cosmetics industry, posted revenues of $402.12 million for the quarter ended May 2026, surpassing the Zacks Consensus Estimate by 7.20%. This compares to year-ago revenues of $371.65 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Helen of Troy shares have added about 32% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for Helen of Troy?While Helen of Troy has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Helen of Troy was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.48 on $435.91 million in revenues for the coming quarter and $3.44 on $1.78 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Cosmetics is currently in the top 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, e.l.f. Beauty (ELF - Free Report) , has yet to report results for the quarter ended June 2026.

This cosmetics company is expected to post quarterly earnings of $0.73 per share in its upcoming report, which represents a year-over-year change of -18%. The consensus EPS estimate for the quarter has been revised 1.2% higher over the last 30 days to the current level.

e.l.f. Beauty's revenues are expected to be $424.55 million, up 20% from the year-ago quarter.

Helen of Troy (NASDAQ:HELE) delivered a surprise first-quarter profit and raised its full-year revenue guidance, pointing to early progress in its multi-year restructuring effort.

The consumer products company posted adjusted earnings per share of $0.17 for the quarter, sharply beating the analyst consensus, which had called for a loss of $0.01 per share.

Net sales climbed 8.2% year-over-year to $402.1 million, topping forecasts of roughly $374.5 million. Growth was broad-based, with the Home & Outdoor segment up 9.5% and Beauty & Wellness rising 7%.

Following the results, management raised its fiscal 2027 revenue guidance to a range of $1.76 billion to $1.83 billion. Adjusted earnings guidance was maintained at $3.25 to $3.75 per share, a level the company said reflects stabilization after steep declines in fiscal 2026.

The results build on Project Pegasus, a multi-year restructuring program aimed at modernizing the business and improving operating margins. As part of that effort, Helen of Troy (NASDAQ:HELE) has been diversifying its supply chain to limit exposure to China-related tariffs, targeting China-sourced products at 25% to 30% of consolidated cost of goods sold by the end of fiscal 2026.

Gross margin fell 110 basis points to 46% in the quarter due to tariff pressure and customer mix, though cost savings from Project Pegasus helped offset the impact.

Management said it is focusing marketing and innovation spending on brands including OXO, Hydro Flask and Osprey, aiming to fund reinvestment through revenue growth.

The company's broader portfolio spans the Home & Outdoor and Beauty & Wellness segments and includes Vicks, Braun, Honeywell, PUR, Hot Tools, Drybar, Curlsmith, Revlon and Olive & June.

Shares of Helen of Troy were down 2.2% on Wednesday morning.

BenzingaEspaña

Italia

대한민국

日本

Français

Benzinga Edge

Benzinga Research

Benzinga Pro

SPY746.160.21%

QQQ707.080.33%

BTC/USD62542.821.2138%

DIA527.810.12%

GLD376.010.39%

TLT84.490.07%

Get Benzinga Pro Data & APIs

Events

Premarket

Advertise

Contribute

España

Italia

대한민국

日本

Français

BenzingaPremium Services

Financial News Financial News

Large Cap Stocks

Small-Cap Stocks

Insider Trades

Earnings

Technology

AI News

Personal Finance

ETF News

Crypto News

Dividend News

Latest Rumors

Latest Offerings News

Investment Ideas Investment Ideas

Stock of the Day

Stock Whisper Index

Analyst Ratings

Analyst Color

Financial Advisors

Government Trades

Trading Ideas

Stock Screener

Markets Markets

Premarket Movers

After Hours

Options

ETFs

Commodities

Prediction Markets

Private Markets

Bonds

Futures

Forex

Top Stocks Top Stocks

Apple (AAPL)

Tesla (TSLA)

Amazon (AMZN)

Nvidia (NVDA)

Alphabet (GOOGL)

Meta Platforms (META)

Microsoft (MSFT)

StreetTracks Gold Shares (GLD)

IBIT Bitcoin Trust (IBIT)

Top Value Stocks

Top Momentum Stocks

Top Growth Stocks

Top Quality Stocks

Learn Learn

Investing Guides

Personal Finance

Mortgages

Best Credit Cards

Best Dividend Stocks

Best Swing Trade Stocks

ResearchMy StocksToolsFree Benzinga Pro Trial Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

FDA Calendar

Guidance Calendar

IPO Calendar

M&A Calendar

Unusual Options Activity Calendar

SPAC Calendar

Stock Split Calendar

Trade Ideas

Stock Reports

Insider Trades

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Heatmaps

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Most Shorted

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Stock Screener

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

SPY746.160.21%

QQQ707.080.33%

BTC/USD62542.821.2138%

DIA527.810.12%

GLD376.010.39%

TLT84.490.07%

July 8, 2026 2:49 AM 1 min read

With U.S. stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Check out our premarket coverage here

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Posted In:

MarketsTrading IdeasPre-Market OutlookLong IdeasNewsEarningsEquitiesMarket SummaryStocks To Watch

Connect With Us

About Benzinga

About UsCareersAdvertiseContact UsMarket Resources

Advanced Stock Screener ToolsOptions Trading Chain AnalysisComprehensive Earnings CalendarDividend Investor Calendar and AlertsEconomic Calendar and Market EventsIPO Calendar and New ListingsMarket Outlook and AnalysisWall Street Analyst Ratings and TargetsTrading Tools & Education

Benzinga Pro Trading PlatformOptions Trading Strategies and NewsStock Market Trading Ideas and AnalysisTechnical Analysis Charts and IndicatorsFundamental Analysis and ValuationDay Trading Guides and StrategiesLive Investor EventsPre-market Stock Analysis and NewsCryptocurrency Market Analysis and NewsRing the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions Do Not Sell My Personal Data/Privacy PolicyDisclaimer Service StatusSitemap©

2026

Benzinga | All Rights Reserved

NEW YORK, July 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Helen of Troy securities between April 24, 2024 and October 8, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/HELE.

Helen of Troy Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that:

Helen of Troy overstated the success and benefits of its Project Pegasus initiative, touting the “fuel” it was generating while downplaying issues such as “implementation hiccups” at its Tennessee distribution center and assuring investors that the project was progressing and delivering cost-saving efficiencies; 
in reality, Project Pegasus was not delivering the efficiencies Defendants claimed, as the Company lacked sufficient resources and budget to achieve its stated restructuring and cost-savings goals; and 
as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading at all relevant times.
What's Next for Helen of Troy Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/HELE. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Helen of Troy you have until August 3, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Helen of Troy Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Helen of Troy Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.